• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides Purine nucleosides
• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides

L-Adenosine (CAS No. 3080-29-3): A Comprehensive Overview

L-Adenosine, also known as adenosine, is a naturally occurring nucleoside that plays a crucial role in various physiological processes. With the chemical formula C₁₀H₁₃N₅O₄, it is identified by the CAS number 3080-29-3. This compound is composed of adenine, a purine base, and ribose, a pentose sugar. Adenosine is widely recognized for its involvement in energy metabolism, neurotransmission, and cardiovascular regulation.

In the context of energy metabolism, adenosine is a key component of adenosine triphosphate (ATP), the primary energy currency of cells. ATP is generated through cellular respiration and is essential for numerous biological processes, including muscle contraction, nerve impulse propagation, and biosynthesis. The breakdown of ATP to adenosine and inorganic phosphate (Pi) releases energy that can be harnessed by cells to perform various functions.

Adenosine also functions as an important neuromodulator in the central nervous system (CNS). It acts on specific adenosine receptors (A₁, A_2A, A_2B, and A₃) to modulate neurotransmitter release and neuronal activity. For instance, activation of A₁ receptors generally leads to inhibitory effects, reducing neuronal firing and promoting sleep. Conversely, activation of A_2A receptors can have excitatory effects, enhancing neurotransmitter release and synaptic plasticity.

In the cardiovascular system, adenosine exerts potent vasodilatory effects by relaxing smooth muscle cells in blood vessels. This action helps to regulate blood flow and maintain cardiovascular homeostasis. Adenosine is also involved in the regulation of heart rate and contractility, making it a valuable therapeutic target for conditions such as angina pectoris and myocardial infarction.

The therapeutic potential of adenosine has been extensively explored in clinical settings. In cardiology, adenosine is used as a diagnostic agent for stress testing to assess coronary artery disease. It is also employed as an antiarrhythmic agent to terminate supraventricular tachycardia (SVT) by slowing conduction through the atrioventricular (AV) node. Additionally, adenosine has been investigated for its anti-inflammatory properties and potential applications in treating inflammatory diseases.

Recent research has shed light on the multifaceted roles of adenosine in various diseases. For example, studies have shown that adenosine signaling pathways are dysregulated in neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Modulating these pathways with adenosine receptor agonists or antagonists may offer new therapeutic strategies for these conditions.

In cancer research, adenosine has been implicated in tumor progression and immune evasion. Tumor cells can release high levels of adenosine into the microenvironment, which can suppress immune cell function and promote tumor growth. Targeting adenosine signaling with specific inhibitors or modulators may enhance the efficacy of cancer immunotherapies.

The pharmacological properties of adenosine have also been studied in the context of pain management. Adenosine receptors are expressed in nociceptive pathways, and activation of these receptors can produce analgesic effects. This has led to the development of novel adenosine-based analgesics that may provide alternative options for pain relief.

In conclusion, L-Adenosine (CAS No. 3080-29-3) is a versatile compound with significant biological importance and therapeutic potential. Its roles in energy metabolism, neurotransmission, cardiovascular regulation, and disease pathogenesis highlight its relevance across multiple fields of research and clinical practice. Ongoing studies continue to uncover new insights into the mechanisms underlying adenosine's actions, paving the way for innovative therapeutic approaches.

• 24356-66-9(Vidarabine monohydrate)
• 10279-87-5(9H-Purin-6-amine, 9-b-D-gulofuranosyl-)
• 4754-39-6(5'-Deoxyadenosine)
• 5536-17-4(Vidarabine)
• 58-61-7(Adenosine)
• 29847-43-6(9H-Purin-6-amine,9-(6-deoxy-a-L-mannofuranosyl)-)
• 10279-89-7(9H-Purin-6-amine, 9-b-D-allofuranosyl-)
• 10279-88-6(9H-Purin-6-amine, 9-b-L-gulofuranosyl-)
• 2006-02-2(9H-Purin-6-amine,9-arabinofuranosyl-)
• 2946-52-3(9H-Purin-6-amine, 9-a-D-xylofuranosyl-)